Table 5.
Summary of the potential prognosis miRs in laryngeal cancer
| MiRs | Deregulation | Molecular mechanisms | Ref. |
|---|---|---|---|
| miR-101 | Downregulation | Low expression of miR-101 was correlated with TNM stage, especially poorer prognosis. | [40] |
| miR-126 | Downregulation | Elevated expression of miR-126 was closely associated with the favorable prognosis of the patients with LSCC. | [56] |
| miR-152 | Downregulation | The expression level of miR-152 was correlated with pT stage and pN stage of supragalottic laryngeal carcinoma. | [57] |
| miR-19a | Upregulation | The high level of miR-19a was positively correlated with decreased overall survival. | [58] |
| miR-21/miR-375 | Upregulation/Downregulation | High miR-21 or low miR-375 expression in tumor tissues predicted poor prognoses. | [59] |
| miR-23a | Upregulation | High expression of miR-23a was significantly correlated with patient five-year survival. | [60] |
| miR-296-5p | Upregulation | The expression of miR-296-5p was substantially related to radioresistance and tumor recurrence in early stage LSCC. | [61] |
| miR-34c-5p | Downregulation | Low miR-34c-5p expression was significantly associated with worse disease-free and overall survival and an increased risk of recurrence. | [62] |